AdialRecent Data Breaches and Security Report

https://adialpharma.com ᛫
Last updated October 26, 2018

Company Details

Company Overview

Adial Pharmaceuticals, Inc. ("the Company") is a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder ("AUD") using its lead investigational new drug product, AD04, a selective serotonin-3 antagonist (i.e., a "5-HT3 antagonist").

Valuation

Employees

CEO

Location

Recent Data Breaches

Stay informed about the most recent data breaches affecting companies like Adial

subscribe to data breach notifications

More Security Reports

Burlington, NC, United States.

Constellation Pharmaceuticals

CNO Financial Group

Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's CSTAR Score ranges from 0 to 950. The higher the score, the more effective a company is in implementing good security practices.

Passed Checks

{{ passedCheck.passTitle }}

Failed Checks

{{ failedCheck.failTitle }}

View a free security report for Adial

Get full security report ›

More Security Reports

Burlington, NC, United States.

Constellation Pharmaceuticals

CNO Financial Group

See UpGuard In Action

Book a call with one of our specialists and we'll arrange a time for a demo.